CDMO Experic has announced the appointment of Denise Sabaday as vice president of business development. Sabaday was most recently Executive VP of Business Development and Marketing at Transformative Pharmaceutical Solutions and was previously Director of Business Development at inVentiv Health Clinical. In October 2018, Experic announced that it had hired OINDP … [Read more...] about Experic appoints Denise Sabaday as VP of Business Development
People
Pneuma Respiratory names Jay Morgan as Chairman of the Board
Pneuma Respiratory, which is developing a digital soft mist inhaler, has announced the appointment of Jay Morgan as Chairman of the Board. Morgan, a former Bayer and Merck executive who has been a member of the board since 2017, will replace Walt Robb as chairman. Robb will remain a member of the board. In 2018, Pneuma Respiratory announced that it had raised $8.3 … [Read more...] about Pneuma Respiratory names Jay Morgan as Chairman of the Board
Circassia appoints Jonathan Emms Chief Operating Officer
Circassia Pharmaceuticals has announced the appointment of Jonathan Emms as Chief Operating Officer and as an Executive Director of the Board of Directors. Emms previously served in a number of executive roles at Pfizer, most recently as Chief Commercial Officer, Internal Medicine. The company also said that Senior VP of R&D Rod Hafner will leave the board, … [Read more...] about Circassia appoints Jonathan Emms Chief Operating Officer
Proveris Scientific adds to its Americas and Asia Pacific customer support team
Proveris Scientific has announced an expansion of its Americas and Asia Pacific customer service support team with the hire of Doug Mann as a Field Service Engineer. The company also recently added Stephen McDonald to its European customer support team. Mann, who most recently provided field support at TTP LabTech, joins Senior Field Service Engineer Kevin O'Keefe … [Read more...] about Proveris Scientific adds to its Americas and Asia Pacific customer support team
George D. Behrakis joins board of AZTherapies
AZTherapies has announced that former Dooner Laboratories and Muro Pharmaceuticals CEO George D. Behrakis has joined the company’s board of directors. Behrakis sold Dooner Laboratories, which manufactured theophylline products for asthma, to Rorer in 1977 and Muro Pharmaceuticals, which marketed a number of OINDPs for the treatment of asthma and allergies, to … [Read more...] about George D. Behrakis joins board of AZTherapies
AZTherapies appoints Jay Mohr as COO, Chief Business Officer, and Head of Commercial Development
AZTherapies, which is developing an inhaled cromolyn sodium/ibuprofen formulation, has named Jay Mohr as Chief Operating Officer, Chief Business Officer, and Head of Commercial Development. Mohr was most recently co-founder and Managing Director of Locust Walk Partners. According to his LinkedIn page, Mohr has some experience with OINDPs, beginning at … [Read more...] about AZTherapies appoints Jay Mohr as COO, Chief Business Officer, and Head of Commercial Development
In Memoriam: Ola Nerbrink
Members of the OINDP community are remembering inhalation expert Ola Nerbrink, who passed away on June 1, 2019. He was the CEO of Respiron Consulting, which he founded in 2009, and VP of Business Development at the Medicon Valley Inhalation Consortium (MVIC), where he had served as CEO from 2014 to 2017. In 2017, he also took a position as Senior Sales Advisor for … [Read more...] about In Memoriam: Ola Nerbrink
Proveris Scientific adds Stephen McDonald to its European support team
Proveris Scientific announced that Stephen McDonald has joined the company's European team, which is based in the UK. McDonald, who has previously worked with Proveris to provide customer support as an independent contractor, will work with European Sales Director Deborah Jones providing customer service support for Europe and the Middle East. McDonald has more … [Read more...] about Proveris Scientific adds Stephen McDonald to its European support team
Theravance Biopharma appoints Andrew Hindman as Senior VP and CFO
Theravance Biopharma has named former Acorda Therapeutics Chief Business Officer Andrew Hindman as Senior VP and Chief Financial Officer. Hindman, who led Acorda's acquisition of Inbrija inhaled L-dopa developer Civitas Therapeutics in 2014, also previously served as President and CEO of Tobira Therapeutics and held executive positions at Onyx Pharmaceuticals and … [Read more...] about Theravance Biopharma appoints Andrew Hindman as Senior VP and CFO
TFF Pharmaceuticals raises over $8 million, announces executive appointments
DPI developer TFF Pharmaceuticals said that is has raised $8.17 million through a Series A preferred stock offering and that it will use the funds for R&D. In April 2018, the company announced that it had raised $14 million for development of inhaled drugs, also through a Series A preferred stock offering. In the past year, TFF has received patents in the … [Read more...] about TFF Pharmaceuticals raises over $8 million, announces executive appointments